Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398619 · ClinicalTrials.gov registry record · Phase 1
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes
A Phase 1 study, sponsored by Incyte Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00398619 is a Phase 1 study that has completed, run by Incyte Corporation.
The verdict
NCT00398619, a Phase 1 study, has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.
Interventions
- DRUG INCB13739
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-11 |
| Est. Completion | 2007-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398619
The ClinicalTrials.gov registry entry for NCT00398619 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INCB13739 is the first listed.
NCT00398619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00398619 about?
NCT00398619 is a clinical study titled "A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes". The purpose of this study is to determine whether the investigational drug INCB013739 has an effect on systemic and adipose tissue 11-HSD1 activity in obese, insulin resistant subjects.
What is the current status of trial NCT00398619?
This trial is currently completed. It is a Phase 1 study. The study started on 2006-11. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00398619?
The interventions under investigation include: INCB13739 (DRUG).
Who is sponsoring clinical trial NCT00398619?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.